The potential use of basigin (CD147) as a prognostic marker in B-cell precursor acute lymphoblastic leukaemia

2010-09-01

British Journal of Haematology , Volume 150 - Issue 5 p. 624- 626

Additional Metadata
Keywords	B cell leukemia, B cell precursor acute lymphoblastic leukemia, CD147 antigen, Western blotting, acute lymphoblastic leukemia, basigin (CD147), cancer relapse, cell migration, cell proliferation, diagnosis-relapse, extramedullary, flow cytometry, gene expression profiling, gene rearrangement, human, immunoglobulin, immunophenotyping, letter, lymphocyte differentiation, messenger RNA, minimal residual disease, normal B cells, paediatric acute lymphoblastic leukaemia, pre B lymphocyte, priority journal, prognosis, protein expression, protein function, quantitative analysis, real time polymerase chain reaction, tumor marker
Persistent URL	doi.org/10.1111/j.1365-2141.2010.08240.x, hdl.handle.net/1765/20852
Journal	British Journal of Haematology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Vries, J.F, te Marvelde, J.G, Wind, H.K, van Dongen, J.J.M, & van der Velden, V.H.J. (2010). The potential use of basigin (CD147) as a prognostic marker in B-cell precursor acute lymphoblastic leukaemia. British Journal of Haematology, 150(5), 624–626. doi:10.1111/j.1365-2141.2010.08240.x

Publication